Long-Term Improvement in Treatment Outcome After Radiotherapy and Hyperthermia in Locoregionally Advanced Cervix Cancer: An Update of the Dutch Deep Hyperthermia Trial

International Journal of Radiation Oncology Biology Physics

Volumn 70, Issue 4, 2008, Pages 1176-1182

  Franckena, Martine ^a   Stalpers, Lukas J A ^b   Koper, Peter C M ^c   Wiggenraad, Ruud G J ^d   Hoogenraad, Wim J ^e   van Dijk, Jan D P ^b   Wárlám Rodenhuis, Carla C ^f   Jobsen, Jan J ^g   van Rhoon, Gerard C ^a   van der Zee, Jacoba ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

^c HagaZiekenhuis ^*  (Netherlands)

^d MEDICAL CENTER HAAGLANDEN   (Netherlands)

^e RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^f UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^g MEDISCH SPECTRUM TWENTE   (Netherlands)

Author keywords

Cervical cancer; Hyperthermia; Long term outcome; Radiotherapy; Randomized study

Indexed keywords

BIODIVERSITY; DISEASE CONTROL; FAILURE ANALYSIS; RADIOTHERAPY; TOXICITY;

CERVICAL CANCER; HYPERTHERMIA; LONG-TERM OUTCOME; RANDOMIZED STUDY;

TUMORS;

ADULT; AGED; ARTICLE; CANCER RADIOTHERAPY; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; GASTROINTESTINAL TOXICITY; HUMAN; HYPERTHERMIC THERAPY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RADIATION DOSE; TREATMENT OUTCOME; TREATMENT RESPONSE; UTERINE CERVIX CANCER; WORLD HEALTH ORGANIZATION;

ADULT; AGED; AGED, 80 AND OVER; COMBINED MODALITY THERAPY; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERTHERMIA, INDUCED; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NETHERLANDS; RADIOTHERAPY DOSAGE; REGRESSION ANALYSIS; REMISSION INDUCTION; SURVIVAL RATE; TREATMENT OUTCOME; UTERINE CERVICAL NEOPLASMS;

EID: 39749186823     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2007.07.2348     Document Type: Article

References (37)

1. Barillot I., Horiot J.C., Pigneux J., et al. Carcinoma of the intact uterine cervix with radiotherapy alone: A French cooperative study: Update and multivariate analysis of prognostic factors. Int J Radiat Oncol Biol Phys 38 (1997) 969-978
2. Perez C.A., Grigsby P.W., Chao K.S., et al. Tumor size, irradiation dose and long-term outcome of carcinoma of the uterine cervix. Int J Radiat Oncol Biol Phys 41 (1998) 307-317
3. Brady L.W., Markoe A.M., Micaily B., et al. Innovative techniques in radiation oncology. Clinical research programs to improve local and regional control in cancer. Cancer 65 (1990) 610-624
4. Suit H.D. The American Society of Therapeutic Radiologists Presidential Address: October 1981. Potential for improving survival rates for the cancer patient by increasing the efficacy of treatment of the primary lesion. Cancer 50 (1982) 1227-1234
5. Van der Zee J., Koper P.C.M., Lutgens L.C.H.W., et al. Point-counterpoint: What is the optimal trial design to test hyperthermia for carcinoma of the cervix?. Int J Hyperthermia 18 (2002) 19-24
6. Field S.B. Biological aspects of hyperthermia. In: Field S.B., and Franconi C. (Eds). Physics and technology of hyperthermia (1987), Martinus Nijhoff, Dordrecht 19-53
7. Kampinga H.H., and Dikomey E. Hyperthermic radiosensitization: Mode of action and clinical relevance. Int J Radiat Biol 77 (2001) 399-408
8. Song C.W., Shakil A., Griffin R.J., et al. Improvement of tumor oxygenation status by mild temperature hyperthermia alone or in combination with carbogen. Semin Oncol 24 (1997) 626-632
9. Valdagni R., Amichetti M., and Pani G. Radical radiation alone versus radical radiation plus microwave hyperthermia for N3 (TNM-UICC) neck nodes: A prospective randomized clinical trial. Int J Radiat Oncol Biol Phys 15 (1988) 13-24
10. Valdagni R., and Amichetti M. Report of long-term follow-up in a randomized trial comparing radiation and radiation therapy plus hyperthermia to metastatic lymph nodes in Stage IV head and neck patients. Int J Radiat Oncol Biol Phys 28 (1994) 163-169
11. Overgaard J., Gonzalez Gonzalez D., Hulshof M.C., et al. Randomised trial of hyperthermia as adjuvant to radiotherapy for recurrent or metastatic malignant melanoma. Lancet 345 (1995) 540-543
12. Vernon C.C., Hand J.W., Field S.B., et al. Radiotherapy with or without hyperthermia in the treatment of superficial localized breast cancer: Results from five randomized controlled trials. Int J Radiat Oncol Biol Phys 35 (1996) 731-744
13. Van der Zee J., Gonzalez Gonzalez D., van Rhoon G.C., et al. Comparison of radiotherapy alone with radiotherapy plus hyperthermia in locally advanced pelvic tumours: A prospective randomized, multicentre trial. Lancet 355 (2000) 1119-1125
14. Van der Zee J., and Gonzalez Gonzalez D. The Dutch Deep Hyperthermia Trial: Results in cervical cancer. Int J Hyperthermia 18 (2002) 1-12
15. Schneider C.J., van Dijk J.D.P., de Leeuw A.A.C., et al. Quality assurance in various radiative hyperthermia systems applying a phantom with LED matrix. Int J Hyperthermia 10 (1994) 733-747
16. Cox J.D., Stetz J., and Pajak T.F. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys 31 (1995) 1341-1346
17. Ito H., Kutuki S., Nishiguchi I., et al. Radiotherapy for cervical cancer with high-dose rate brachytherapy-Correlation between tumor size, dose and failure. Radiother Oncol 31 (1994) 240-247
18. Kapp K.S., Stuecklschweiger G.F., Kapp D.S., et al. Prognostic factors in patients with carcinoma of the uterine cervix treated with external beam irradiation and IR-192 high-dose-rate brachytherapy. Int J Radiat Oncol Biol Phys 42 (1998) 531-540
19. Green J.A., Kirwan J.M., Tierney J.F., et al. Survival and recurrence after concomitant chemotherapy and radiotherapy for cancer of the uterine cervix: A systemic review and meta-analysis. Lancet 358 (2001) 781-786
20. Keys H.M., Bundy B.N., Stehman F.B., et al. Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma. N Engl J Med 340 (1999) 1154-1161
21. Morris M., Eifel P.J., Lu J., et al. Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer. N Engl J Med 340 (1999) 1137-1143
22. Rose P.G., Bundy B.N., Watkins E.B., et al. Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer. N Engl J Med 340 (1999) 1144-1153
23. Whitney C.W., Sause W., Bundy B.N., et al. Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes. J Clin Oncol 17 (1999) 1339-1348
24. Peters W.A., Liu P.Y., Barret R.J., et al. Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix. J Clin Oncol 18 (2000) 1606-1613
25. National Cancer Institute. Clinical announcement: Concurrent chemoradiation for cervical cancer. February 22, 1999. Available at: http://www.cancer.gov/newscenter/cervicalcancer/print?page=&keyword=. Accessed March 6, 2007.
26. Pearcey R., Brundage M., Drouin P., et al. Phase III trial comparing radical radiotherapy with and without cisplatin in patients with advanced squamous cell cancer of the cervix. J Clin Oncol 20 (2002) 966-972
27. Petereit D.G., Sarkaria J.R., Chappell R., et al. The adverse effects of treatment prolongation in cervical carcinoma. Int J Radiat Oncol Biol Phys 32 (1995) 1301-1307
28. Kirwan J.M., Symonds P., Green J.A., et al. A systematic review of acute and late toxicity of concomitant chemoradiation for cervical cancer. Radiother Oncol 68 (2003) 217-226
29. Hauer-Jensen M. Late radiation injury of the small intestine. Clinical, pathophysiologic and radiobiological aspects. A review. Acta Oncol 29 (1990) 401-415
30. Wang C.J., Leung S.W., Chen H.C., et al. The correlation of acute toxicity and late rectal injury in radiotherapy for cervical carcinoma: Evidence suggestive of consequential late effect (CQLE). Int J Radiat Oncol Biol Phys 40 (1998) 85-91
31. Datta N.R., Bose A.K., and Kapoor H.K. Thermoradiotherapy in the management of carcinoma cervix (stage IIIB): A controlled clinical study. Indian Med Gaz 121 (1987) 68-71
32. Chen H.W., Jun-Jie F., and Wei L. A randomized trial of hyperthermo-radiochemotherapy for uterine cervix cancer. Chin J Clin Oncol 24 (1997) 249-251
33. Harima Y., Nagata K., Harima K., et al. A randomized clinical trial of radiation therapy versus thermoradiotherapy in stage IIIB cervical carcinoma. Int J Hyperthermia 17 (2001) 97-105
34. Sharma S., Patel F.D., Sandhu A.P., et al. A prospective randomized study of local hyperthermia as a supplement and radiosensitizer in the treatment of carcinoma of the cervix with radiotherapy. Endocuriether/Hyperthermia Oncol 5 (1989) 151-159
35. Vasanthan A., Mitsumori M., Park J.H., et al. Regional hyperthermia combined with radiotherapy for uterine cervical cancers: A multi-institutional prospective randomized trial of the Atomic Energy Agency. Int J Radiat Oncol Biol Phys 61 (2005) 145-153
36. Van der Zee J., van Rhoon G.C., and Wust P. In regard to Dr. Vasanthan et al. Int J Radiat Oncol Biol Phys 61 (2005) 145-153
37. Westermann A.M., Jones E.L., Schem B.-C., et al. First results of triple modality treatment combining radiotherapy, chemotherapy and hyperthermia for treatment in patients with stage IIB, III and IVA cervical carcinoma. Cancer 104 (2005) 763-770